Medtronic touts retrospective data in Reactive ATP therapy AF study

This study does exactly that. It helps us understand how Reactive ATP impacts the burden of persistent atrial fibrillation in a larger and more varied group of patients than we might normally be able to study within the constraints of a controlled trial,” cardiac rhythm and heart failure division chief medical officer Dr. Rob Kowal said in a prepared statement.
Last week, Medtronic said its nano-sized Micra pacemaker will be heading into space as part of a Nebraska high school student’s science project.
The post Medtronic touts retrospective data in Reactive ATP therapy AF study appeared first on MassDevice.

Source: Mass Device - June 19, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Assist Devices Cardiac Implants Cardiovascular Clinical Trials Medtronic Source Type: news